Product
Octaplex
3 clinical trials
3 indications
Indication
Acute Major BleedingIndication
Bleeding Patients After Cardiac SurgeryIndication
Bleeding RiskClinical trial
Study of Four-factor Prothrombin Complex Concentrate, OCTAPLEX, in Patients With Acute Major Bleeding on Direct Oral Anticoagulant (DOAC) Therapy With Factor Xa InhibitorStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Prospective, Multicentre, Active-control Randomised Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Bleeding Adult Cardiac Surgical PatientsStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
A Phase III, Randomized, Double-blind, Multicenter Study to Assess the Efficacy and Safety of OCTAPLEX, a Four-factor Prothrombin Complex Concentrate (4F-PCC), Compared to the 4F-PCC Beriplex® P/N (Kcentra), for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.Status: Completed, Estimated PCD: 2022-02-23